Appreciate the work that went into this and the write up on the data. Statistics like these baffle me but I'm trying to follow the complexities and understand.

1. Are the 3 companies on a schedule as to when each one releases their toxic batches? Each knows their window, then they step aside and the next one goes? Or they release whatever batch they plan during their window- toxic or untoxic?

2. I wonder why J&J had such a low number of events. Are all/most of the initial myocarditis events for J&J from just those 2 batches?

3. For the toxic batches, wonder if they are just just more concentrated or do those batches have different ingredients. Could the Graphene be in only some batches?

4. If someone received vaccines from a toxic batch and did not experience adverse events beyond the usual, are they a ticking time bomb and their adverse events will come later - 6 mos to a year?